Endocrine Society GUIDELINES Bundle (free trial)

Hyperglycemia

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/302976

Contents of this Issue

Navigation

Page 1 of 9

Key Points Î Hyperglycemia is a common, serious, and costly health care problem in hospitalized patients. Î Observational and randomized controlled studies indicate that improvement in glycemic control results in lower rates of hospital complications in general medicine and surgery patients. Î Implementing a standardized subcutaneous (subcut) insulin order set promoting the use of scheduled basal and nutritional insulin therapy is a key intervention in the inpatient management of diabetes. Assessment Î The Endocrine Society (ES) recommends that clinicians assess all patients admitted to the hospital for a history of diabetes. When present, this diagnosis should be clearly identified in the medical record. (1|⊕ ) Î The ES suggests admission laboratory blood glucose (BG) testing for all patients, independent of a prior diagnosis of diabetes. (2|⊕ ) Î For patients without a history of diabetes, the ES recommends bedside point of care (POC) testing for ≥ 24-48 h if BG > 7.8 mmol/L (140 mg/dL). Those with BG > 7.8 mmol/L require ongoing POC testing with appropriate therapeutic intervention. (1|⊕ ) Î The ES recommends monitoring previously normoglycemic patients receiving therapies associated with hyperglycemia — such as corticosteroids or octreotide, enteral nutrition (EN) and parenteral nutrition (PN) — with bedside POC testing for ≥ 24 to 48 h after initiation of these therapies. Those with BG measures > 7.8 mmol/L (140 mg/dL) require ongoing POC testing with appropriate therapeutic intervention. (1|⊕ ) Î The ES recommends a hemoglobin A1c (HbA1c) level in patients with known diabetes or with hyperglycemia (> 7.8 mmol/L) if this has not been performed in the preceding 2-3 months. (1|⊕ ) Monitoring in the Noncritical Care Setting Î The ES recommends bedside capillary POC testing as the preferred method for guiding ongoing glycemic management of individual patients. (1|⊕⊕ ) Î The ES recommends the use of BG monitoring devices that have demonstrated accuracy in acutely ill patients. (1|⊕ ) Î The ES recommends that timing of glucose measurements matches the patient's nutritional intake and medication regimen. (1|⊕ ) Î The ES suggests the following schedules for POC testing: • before meals and at bedtime in patients who are eating • every 4-6 h in patients who are NPO or receiving continuous EN. (2|⊕ )

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Hyperglycemia